Biogen (BIIB) Given a $427.00 Price Target by Mizuho Analysts

Biogen (BIIB) Given a $427.00 Price Target by Mizuho Analysts


The brokerage currently has a buy rating on the biotechnology company's stock. A number of other analysts have also weighed in on the stock.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога